Equity

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Novartis India LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500672 P/E (TTM) :18.04
ISIN Demat:INE234A01025 Div & Yield %:3.21 EPS (TTM) :43.17
Book Value (RS) :313.912669 Market Cap (Rs Cr.):1923.41 Face Value (RS) :5
    Change Company 
Particulars Quarter Ended
(Sep 2025)
Quarter Ended
(Sep 2024)
Quarter Ended
(% Var)
Sales 90.33 87.10 3.71
Other Income 9.40 10.32 -8.91
PBIDT 33.28 28.28 17.68
Interest 0.11 0.14 -21.43
PBDT 33.17 28.14 17.87
Depreciation 0.52 0.58 -10.34
PBT 32.65 27.56 18.47
Tax 8.48 8.22 3.16
Deferred Tax -0.05 -1.07 0.00
PAT 24.22 20.41 18.67

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)